# Value of Cabergoline and Low Dose Aspirin in Poor Responders Undergoing ICSI-ET With GnRH Agonist Flare-Up-Protocol

> **NCT03263299** · PHASE4 · UNKNOWN · sponsor: **Cairo University** · enrollment: 120 (estimated)

## Conditions studied

- Invitro Fertilization

## Interventions

- **DRUG:** cabergoline
- **DRUG:** Aspirin
- **DRUG:** GnRH agonist

## Key facts

- **NCT ID:** NCT03263299
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-08
- **Primary completion:** 2018-08
- **Final completion:** 2018-09
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2017-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03263299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03263299, "Value of Cabergoline and Low Dose Aspirin in Poor Responders Undergoing ICSI-ET With GnRH Agonist Flare-Up-Protocol". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03263299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*